Nancy Stuart - Concert Pharmaceuticals Chief Officer
| CNCEDelisted Stock | USD 8.37 0.01 0.12% |
Executive
Ms. Nancy Stuart is the Chief Operating Officer of Concert Pharmaceuticals Inc. Ms. Stuart has served as our Chief Operating Officer since October 2007 and was our Senior Vice President, Corporationrationrate Strategy and Operations from July 2006 to October 2007. Prior to joining Concert, Ms. Stuart held various business operations and business development positions at Amgen Inc., a biopharmaceutical company, Kinetix Pharmaceuticals, Inc., a pharmaceutical company subsequently acquired by Amgen, Scion Pharmaceuticals, Inc., a pharmaceutical company, Vertex Pharmaceuticals Incorporated and Genzyme Corporation since 2007.
| Age | 65 |
| Tenure | 17 years |
| Professional Marks | MBA |
| Phone | 781 860 0045 |
| Web | https://www.concertpharma.com |
Concert Pharmaceuticals Management Efficiency
The company has return on total asset (ROA) of (0.3853) % which means that it has lost $0.3853 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.0868) %, meaning that it created substantial loss on money invested by shareholders. Concert Pharmaceuticals' management efficiency ratios could be used to measure how well Concert Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.Concert Pharmaceuticals currently holds 14.51 M in liabilities with Debt to Equity (D/E) ratio of 0.11, which may suggest the company is not taking enough advantage from borrowing. Concert Pharmaceuticals has a current ratio of 9.83, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Concert Pharmaceuticals' use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Wayne Young | GoHealth | N/A | |
| Veronica Romano | Old Republic International | N/A | |
| Michael Joyce | Sun Life Financial | N/A | |
| Bradley CPA | RCI Hospitality Holdings | 40 | |
| Kivin Jones | Old Republic International | N/A | |
| Gary Fishman | RCI Hospitality Holdings | N/A | |
| Carolyn Monroe | Old Republic International | 65 | |
| Jeffrey Lange | Old Republic International | 53 | |
| Jason Schulz | GoHealth | 47 | |
| Stephen Moffat | GoHealth | N/A | |
| Alison Moriarty | GoHealth | N/A | |
| Bradley Esq | GoHealth | 46 | |
| Aaron CPA | Old Republic International | 53 | |
| John III | GoHealth | N/A | |
| Patrick Dalton | Kinsale Capital Group | N/A | |
| Blair Kessler | GoHealth | N/A | |
| Brendan Shanahan | GoHealth | 61 | |
| Michael Kelley | GoHealth | N/A | |
| Amanda Viol | Kinsale Capital Group | N/A | |
| Larry Madge | Sun Life Financial | N/A | |
| Katherine OHalloran | GoHealth | N/A | |
Management Performance
| Return On Equity | -1.09 | |||
| Return On Asset | -0.39 |
Concert Pharmaceuticals Leadership Team
Elected by the shareholders, the Concert Pharmaceuticals' board of directors comprises two types of representatives: Concert Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Concert. The board's role is to monitor Concert Pharmaceuticals' management team and ensure that shareholders' interests are well served. Concert Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Concert Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Nancy Stuart, Chief Officer | ||
| James Cassella, Senior Vice President chief development officer | ||
| Marc Becker, Chief Officer | ||
| Christine Boisclair, Vice President - Regulatory Affairs | ||
| Justine Koenigsberg, VP of Corporate Communications and Investor Relations | ||
| Jeffrey Munsie, Chief Sec | ||
| Nabil PharmD, VP Devel | ||
| Roger Tung, Co-Founder, CEO and President and Director | ||
| Mba MBA, CoFounder Chairman |
Concert Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Concert Pharmaceuticals a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.09 | |||
| Return On Asset | -0.39 | |||
| Operating Margin | (2.88) % | |||
| Current Valuation | 86.63 M | |||
| Shares Outstanding | 48.02 M | |||
| Shares Owned By Insiders | 3.77 % | |||
| Shares Owned By Institutions | 77.05 % | |||
| Number Of Shares Shorted | 1.08 M | |||
| Price To Earning | 3.08 X | |||
| Price To Book | 1.67 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Consideration for investing in Concert Stock
If you are still planning to invest in Concert Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Concert Pharmaceuticals' history and understand the potential risks before investing.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| CEOs Directory Screen CEOs from public companies around the world |